APA
CRL icon

American Portfolios Advisors’s Charles River Laboratories CRL Stock Holding History

American Portfolios Advisors’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$327K Sell
1,661
-34
-2% -$7.34K 0.01% 816
2022
Q2 		$363K Sell
1,695
-1,132
-40% -$277K 0.01% 800
2022
Q1 		$803K Sell
2,827
-666
-19% -$205K 0.03% 559
2021
Q4 		$1.32M Buy
3,493
+335
+11% +$130K 0.04% 399
2021
Q3 		$1.3M Sell
3,158
-94
-3% -$39K 0.05% 363
2021
Q2 		$1.2M Buy
3,252
+167
+5% +$55.8K 0.05% 389
2021
Q1 		$894K Buy
3,085
+386
+14% +$107K 0.04% 441
2020
Q4 		$674K Buy
2,699
+154
+6% +$36.7K 0.03% 465
2020
Q3 		$576K Buy
2,545
+9
+0.4% +$1.87K 0.03% 438
2020
Q2 		$442K Buy
2,536
+1,170
+86% +$187K 0.03% 471
2020
Q1 		$172K Sell
1,366
-231
-14% -$34.6K 0.01% 699
2019
Q4 		$244K Buy
1,597
+76
+5% +$10.5K 0.02% 674
2019
Q3 		$201K Buy
1,521
+48
+3% +$6.44K 0.02% 714
2019
Q2 		$209K Buy
1,473
+36
+3% +$4.88K 0.02% 700
2019
Q1 		$209K Buy
1,437
+87
+6% +$11.4K 0.02% 626
2018
Q4 		$153K Sell
1,350
-77
-5% -$9.64K 0.02% 599
2018
Q3 		$192K Hold
1,427
– – 0.02% 596
2018
Q2 		$160K Sell
1,427
-16
-1% -$1.73K 0.02% 642
2018
Q1 		$154K Buy
1,443
+129
+10% +$13.9K 0.02% 614
2017
Q4 		$144K Buy
+1,314
New +$143K 0.02% 618

Other funds holding CRL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

American Portfolios Advisors's CRL Position: Q3 2022 in Review

American Portfolios Advisors reduced its Charles River Laboratories (CRL) stake by 2% in Q3 2022, selling an estimated $7.34K and leaving 1,661 shares worth $327K. The position accounts for 0.01% of the portfolio, ranked #816.

American Portfolios Advisors first reported a position in CRL in Q4 2017 and has held it in 20 quarters since. The position peaked at $1.32M in Q4 2021. 584 funds tracked by Wall St. Rank hold CRL as of Q3 2022.

  • American Portfolios Advisors held 1,661 shares of Charles River Laboratories worth $327K as of Q3 2022.
  • American Portfolios Advisors sold 34 Charles River Laboratories shares in Q3 2022, an estimated $7.34K.
  • Charles River Laboratories made up 0.01% of American Portfolios Advisors's portfolio in Q3 2022, its #816 holding.
  • American Portfolios Advisors first reported a position in Charles River Laboratories in Q4 2017 and has held it in 20 quarters since.
  • American Portfolios Advisors's Charles River Laboratories position peaked at $1.32M in Q4 2021.
  • 584 funds tracked by Wall St. Rank held Charles River Laboratories as of Q3 2022.

Based on American Portfolios Advisors's 13F filing for Q3 2022, filed 17 Mar 2023.